Quarterly report pursuant to Section 13 or 15(d)

Segment Information - Schedule of Segment Information (Details)

v3.23.3
Segment Information - Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Segment Reporting Information [Line Items]          
Revenues, net $ 8,365 $ 24,200 $ 40,885 $ 100,824  
Cost of revenue 6,038 12,227 21,590 41,453  
Depreciation and amortization expense 2,571 1,019 4,325 3,392  
Operating and other expenses 6,541 9,176 26,105 27,882  
Income (loss) from operations, before income taxes (6,785) 1,777 (11,135) 28,097  
Income tax benefit (expense) 1,644 (809) 3,104 (7,190)  
Total (loss) income from operations, after income taxes (5,141) 968 (8,031) 20,907  
Net (loss) income (5,141) 968 (8,031) 20,907  
Total assets 91,710   91,710   $ 87,648
Diagnostic services          
Segment Reporting Information [Line Items]          
Revenues, net 2,491 20,541 24,849 91,613  
Cost of revenue 1,798 8,452 10,812 33,558  
Depreciation and amortization expense 1,916 584 3,059 1,755  
Income (loss) from operations, before income taxes (2,512) 6,776 4,902 39,671  
Total assets 46,496   46,496   50,832
Consumer products          
Segment Reporting Information [Line Items]          
Revenues, net 5,874 3,659 16,036 9,211  
Cost of revenue 4,240 3,775 10,778 7,895  
Depreciation and amortization expense 655 435 1,266 1,637  
Income (loss) from operations, before income taxes (1,384) (3,214) (874) (5,390)  
Total assets 41,423   41,423   22,080
Unallocated corporate          
Segment Reporting Information [Line Items]          
Income (loss) from operations, before income taxes (2,889) $ (1,785) (15,163) $ (6,184)  
Total assets $ 3,791   $ 3,791   $ 14,736